<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00302965</url>
  </required_header>
  <id_info>
    <org_study_id>2004341-01</org_study_id>
    <nct_id>NCT00302965</nct_id>
  </id_info>
  <brief_title>Effectiveness of Plasma Transfusions in Critical Care Patients</brief_title>
  <official_title>Effectiveness of Fresh Frozen Plasma in Critical Care (EPICC) Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ottawa Hospital Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ottawa Hospital Research Institute</source>
  <brief_summary>
    <textblock>
      Measuring the effectiveness of plasma transfusions in critical care
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Measuring the effectiveness of plasma transfusions in critical care
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2005</start_date>
  <completion_date type="Actual">December 2006</completion_date>
  <primary_completion_date type="Actual">December 2006</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the proportion of patients with a correction of the INR (Determined by the treating physician)</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Secondary outcomes include changes in coagulation tests (INR, aPTT and individual coagulation factor levels</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>bleeding and complications from FFP (fluid overload, transfusion reactions).</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary outcomes include changes in coagulation tests (INR, aPTT and individual coagulation factor levels</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>bleeding and complications from FFP (fluid overload, transfusion reactions).</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Coagulation</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Frozen Plasma</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ICU Admission

          -  INR &gt; 1.2

          -  Require FFP for active bleeding and/or prior to an invasive procedure

          -  Are able to provide consent or proxy consent

        Exclusion Criteria:

          -  Congenital or acquired coagulation factor deficiency

          -  Platelet count &lt; 50 x 109 /L and have NOT received subsequent platelet transfusion

          -  Consumptive coagulopathy (bleeding ≥ 3 sites and ↓ plts, ↓ fib, ↑ d dimer)

          -  Uncontrolled bleeding (6 or more units of blood in the last 6 hours)

          -  Receiving therapeutic doses of heparin/heparinoid (must be off for at least 6 hours)

          -  Have received clotting factor concentrates in the previous 24 hours

          -  Are expected to require surgery in the next 48 hours

          -  Survival expected to be less than 48 hours

          -  Currently enrolled in another study with a similar outcome

          -  Previous enrollment in this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alan Tinmouth, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>OHRI</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ottawa Hospital</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1H 8L6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>March 13, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2006</study_first_posted>
  <last_update_submitted>October 17, 2008</last_update_submitted>
  <last_update_submitted_qc>October 17, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2008</last_update_posted>
  <keyword>Plasma</keyword>
  <keyword>Trauma</keyword>
  <keyword>Critical Care</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

